Scinai Immunotherapeutics Ltd. American Depositary Shares

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCNI and other ETFs, options, and stocks.

About SCNI

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. 

CEO
Amir Reichman
CEOAmir Reichman
Employees
31
Employees31
Headquarters
Jerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded
2003
Founded2003
Employees
31
Employees31

SCNI Key Statistics

Market cap
649.98K
Market cap649.98K
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
—
Dividend yield—
Average volume
35.80K
Average volume35.80K
High today
$0.8102
High today$0.8102
Low today
$0.7591
Low today$0.7591
Open price
$0.8008
Open price$0.8008
Volume
19.44K
Volume19.44K
52 Week high
$6.18
52 Week high$6.18
52 Week low
$0.613
52 Week low$0.613
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.